L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia

被引：41

作者：

Bonelli, SB

Ransmayr, G

Steffelbauer, M

Lukas, T

Lampl, C

Deibl, M

机构：

[1] Linz Gen Hosp, Dept Neurol & Psychiat, A-4020 Linz, Austria

[2] Innsbruck Med Univ, Dept Biostat, Innsbruck, Austria

来源：

NEUROLOGY | 2004年 / 63卷 / 02期

关键词：

D O I：

10.1212/01.WNL.0000130194.84594.96

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The authors analyzed whether nondemented (PD) and demented Parkinson patients (PDD) and patients with dementia with Lewy bodies (DLB) respond similarly in the levodopa test (LDT). Percentage of motor improvement was similar in the three groups; the proportion of patients with 10% and more improvement was greater in PD than in PDD and DLB. Positive LDT was predictive for favorable response in chronic levodopa treatment, but also some nonresponsive demented patients profited from chronic levodopa therapy.

引用

页码：376 / 378

页数：3

共 10 条

[1]

Ballard C, 1997, ACTA NEUROL SCAND, V96, P366

[2] Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study [J].

Burn, DJ ;

Rowan, EN ;

Minett, T ;

Sanders, J ;

Myint, P ;

Richardson, J ;

Thomas, A ;

Newby, J ;

Reid, J ;

O'Brien, JT ;

McKeith, IG .

MOVEMENT DISORDERS, 2003, 18 (08) :884-889

[3] Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases [J].

Duda, JE ;

Giasson, BI ;

Mabon, ME ;

Lee, VMY ;

Trojanowski, JQ .

ANNALS OF NEUROLOGY, 2002, 52 (02) :205-210

[4] SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders [J].

Litvan, I ;

Bhatia, KP ;

Burn, DJ ;

Goetz, CG ;

Lang, AE ;

McKeith, I ;

Quinn, N ;

Sethi, KD ;

Shults, C ;

Wenning, GK .

MOVEMENT DISORDERS, 2003, 18 (05) :467-486

[5] Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop [J].

McKeith, IG ;

Galasko, D ;

Kosaka, K ;

Perry, EK ;

Dickson, DW ;

Hansen, LA ;

Salmon, DP ;

Lowe, J ;

MIrra, SS ;

Byrne, EJ ;

Lennox, G ;

Quinn, NP ;

Edwardson, JA ;

Ince, PG ;

Bergeron, C ;

Burns, A ;

Miller, BL ;

Lovestone, S ;

Collerton, D ;

Jansen, ENH ;

Ballard, C ;

deVos, RAI ;

Wilcock, GK ;

Jellinger, KA ;

Perry, RH .

NEUROLOGY, 1996, 47 (05) :1113-1124

[6] Evolution of the response to levodopa during the first 4 years of therapy [J].

Nutt, JG ;

Carter, JH ;

Lea, ES ;

Sexton, GJ .

ANNALS OF NEUROLOGY, 2002, 51 (06) :686-693

[7] Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease [J].

Ransmayr, G ;

Seppi, K ;

Donnemiller, E ;

Luginger, E ;

Marksteiner, J ;

Riccabona, G ;

Poewe, W ;

Wenning, GK .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (10) :1523-1528

[8] VASCULAR DEMENTIA - DIAGNOSTIC-CRITERIA FOR RESEARCH STUDIES - REPORT OF THE NINDS-AIREN INTERNATIONAL WORKSHOP [J].

ROMAN, GC ;

TATEMICHI, TK ;

ERKINJUNTTI, T ;

CUMMINGS, JL ;

MASDEU, JC ;

GARCIA, JH ;

AMADUCCI, L ;

ORGOGOZO, JM ;

BRUN, A ;

HOFMAN, A ;

MOODY, DM ;

OBRIEN, MD ;

YAMAGUCHI, T ;

GRAFMAN, J ;

DRAYER, BP ;

BENNETT, DA ;

FISHER, M ;

OGATA, J ;

KOKMEN, E ;

BERMEJO, F ;

WOLF, PA ;

GORELICK, PB ;

BICK, KL ;

PAJEAU, AK ;

BELL, MA ;

DECARLI, C ;

CULEBRAS, A ;

KORCZYN, AD ;

BOGOUSSLAVSKY, J ;

HARTMANN, A ;

SCHEINBERG, P .

NEUROLOGY, 1993, 43 (02) :250-260

[9] Acute challenge with apomorphine and levodopa in parkinsonism [J].

Rossi, P ;

Colosimo, C ;

Moro, E ;

Tonali, P ;

Albanese, A .

EUROPEAN NEUROLOGY, 2000, 43 (02) :95-101

[10]

S Fahn, 1987, RECENT DEV PARKINSON

← 1 →